SEC Company Response from ALTAIR NANOTECHNOLOGIES INC (CIK 0001016546) — Jul 20, 2005
ALTAIR NANOTECHNOLOGIES INC (CIK 0001016546)
Date: July 20, 2005 · CIK: 0001016546 · Accession: 0001019687-05-001999
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
Altair Corresp
[Altair
Nanotechnologies, Inc. letterhead]
July
19,
2005
FILED
VIA
EDGAR WITH FACSIMILE COPY
Mr.
Rufus
Decker
Accounting
Branch Chief
Scott
Watkinson
Staff
Accountant
Division
of Corporation Finance
Mail
Stop
0510
100
F
Street, Northeast
Securities
and Exchange Commission
Washington,
D.C. 20549-0510
Facsimile
No. (202) 772-9368
Dear
Messrs. Decker and Watkinson,
On
behalf
of Altair Nanotechnologies Inc. and its consolidated subsidiaries (collectively,
“Altair” or the “Company”), I am writing in response to your letter to Altair
dated June 17, 2005 (your “Letter”). For clarity, each of the responses is
preceded by a bolded restatement of your request.
Form
10-K/A for the Year Ended December 31, 2004
General
1.
Where
a comment below requests additional disclosures or other revisions
please
show us your supplemental response what the revisions will look like.
These revisions should be included in your future filings, including
your
interim filings where
applicable.
Management’s
Discussion and Analysis, page 31
Results
of Operations - Fiscal Year 2004 vs. 2003, page 37
2.
Please
revise your disclosure to clarify the nature of the issues underlying
the
issuance of $235,000 in common stock “in connection with an agreement
resolving certain issues raised by [a] shareholder” in
2004.
Following
is revised disclosure to clarify
the nature of the issues underlying the issuance of $235,000 in common stock
in
connection with an agreement resolving certain issues raised by a shareholder
in
2004.
Messrs.
Rufus Decker and Scott Watkinson
July
19,
2005 Page 2
“Our
general and administrative expenses increased by $2,036,346, from $3,015,829
in
2003 to $5,052,175 in 2004. G&A labor increased by $604,000 from $1,269,000
in 2003 to $1,873,000 in 2004 due to salary increases, employee bonuses, an
increase in the cost of employee benefit plans and the net addition of three
new
employees. Investor relations expenses increased by $305,000, from $225,000
in
2003 to $530,000 in 2004, as a result of increased investor relations programs
aimed at increasing investor awareness of Altair. In 2004, we incurred an
expense of $235,000 representing the value of common shares issued to a
shareholder in connection with an
agreement with a shareholder resolving various issues, including claims for
reimbursement for payments allegedly made by the shareholder for and on behalf
of the Company and a dispute over registration rights of certain common shares
owned by the shareholder. Consulting
fees increased by $270,000, from $93,000 in 2003 to $363,000 in 2004, primarily
as a result of consultants hired to assist with marketing and product
development in both the performance materials and life sciences divisions.
Legal
expenses increased by $257,000, from $293,000 in 2003 to $550,000 in the 2004,
due to patent costs associated with performance materials and life sciences
products, and a settlement agreement involving a shareholder. Accounting fees
increased by $124,000, from $112,000 during 2003 to $236,000 in 2004, primarily
as a result of costs associated with the Sarbanes-Oxley Act. General office
expenses increased by $172,000, from $387,000 in 2003 to $559,000 in 2004,
primarily as a result of additional purchases of office supplies and equipment
as well as higher costs for utilities, telephone, postage and printing. Director
fees and expenses increased by $108,000, from $16,000 in 2003 to $124,000 in
2004, due to the addition of two non-employee directors and an increase in
the
fees paid to directors. Insurance expense increased by $65,000, from $154,000
in
2003 to $219,000 in 2004, as a result of increased premiums for liability
insurance. Shareholder information expenses increased by $43,000, from $69,000
in 2003 to $112,000 in 2004, due to annual report printing and mailing costs;
the number of shareholders owning our stock increased substantially in 2004.
These increases were partially offset by a decrease in stock option expense
of
$194,000 which occurred due to a reduction in value of repriced stock
options.”
Financial
Statements
Note
8 - Other Transactions, page F-17
3.
Please
provide us with additional information to help us understand the
appropriateness of reflecting the value of warrants issues and repriced
during 2002 and 2003 as preferential warrant dividends and how you
concluded these amounts should not be expensed. Your response should
include references to authoritative literature supporting your accounting.
Please also tell us who the shareholder is and describe any relationship
you have with the shareholder, including business, employment or
other
relationship. Please tell us the number of shares this shareholder
owned
just before each of these transactions as
well.
During
2002 and 2003, the Company reduced the exercise price of certain warrants held
by selected shareholders as an inducement for them to exercise their warrants
for financing purposes. These warrants were originally issued to investors
at
the same time these investors acquired common shares. In a separate transaction
during 2003, the Company issued additional warrants to one shareholder as an
inducement for the shareholder to exercise their existing warrants for financing
purposes. None of these investors has any other relationship with the Company
other than being shareholders, and all were issued the warrants as a “sweetener”
in the equity transaction.
Messrs.
Rufus Decker and Scott Watkinson
July
19,
2005 Page 3
The
warrants were detachable free-standing instruments and therefore, when the
warrants were issued, the Company allocated the fair value of the common stock
between the warrants and the common stock based on their relative fair
values.
The
modification of the warrants and the amount of the dividend was calculated
in
accordance with FASB Statement No. 123, Accounting
for Stock-Based Compensation (SFAS
123), paragraph 35. We presented the cost of the modifications as a preferential
warrant dividend because it was only offered to select shareholders and was
not
given to all shareholders therefore making it preferential.
In
addition, there is guidance in APB Opinion No. 29, Accounting
for Nonmonetary Transactions (APB
29),
that supports recognition of nonmonetary distributions to owners at fair value.
Paragraph 23 of APB 29 states, in part:
“…Other
nonreciprocal transfers of nonmonetary assets to owners should be accounted
for
at fair value if the fair value of the nonmonetary asset distributed is
objectively measurable and would be clearly realizable to the distributing
entity in an outright sale at or near the time of the
distribution…”
Because
the modification of the warrants was offered to only two shareholders who
rendered no other services to the Company or have any other relationships with
the Company, we believe that the appropriate accounting treatment was to reflect
the modification as a preferential dividend to these shareholders. That is,
the
Company transferred value to the investors by reducing the exercise price of
their warrants (or issuing replacement warrants) and did not receive any form
of
compensation in return for this value transferred to the investors. Accordingly,
the Company accounted for the additional value transferred to the investors
as a
distribution or dividend.
We
note
that EITF Topic D-42, The
Effect on the Calculation of Earnings per Share for the Redemption or Induced
Conversion of Preferred Stock
(EITF
D-42), addresses the accounting for an inducement to shareholders to convert
preferred stock, which we believe the accounting treatment would be similar
for
this inducement to convert the warrants. EITF Topic D-42 states in
part:
“...If
convertible preferred stock is converted to other securities issued by the
registrant pursuant to an inducement offer, the staff believes that the excess
of (1) the fair value of all securities and other consideration transferred
in
the transaction by the registrant to the holders of the convertible preferred
stock over (2) the fair value of securities issuable pursuant to the original
conversion terms should be subtracted from net earnings to arrive at net
earnings available to common shareholders in the calculation of earnings per
share…”
We
believe the concept in EITF D-42 is very similar the modification of the
warrants. EITF D-42 addresses a situation in which value is transferred to
the
holders of equity securities for which no compensation is received. Accordingly,
the value transferred to the preferred shareholders is recognized as a
distribution or dividend to preferred shareholders. Furthermore, we believe
the
value transferred to the investors by reducing the exercise price of their
warrants or issuing replacement warrants meets the conceptual definition of
a
distribution in paragraph 67 of Statements of Financial Accounting Concepts
No.
6 which states, in part:
Messrs.
Rufus Decker and Scott Watkinson
July
19,
2005 Page 4
“…Distributions
to owners are decreases in equity of a particular business enterprise resulting
from transferring assets, rendering services, or incurring liabilities by
the
enterprise to owners. Distributions to owners decrease ownership interest
(or
equity) in an enterprise…”
Based on the above guidance, the Company believes that the
charge
was properly accounted for as a dividend rather than an expense.
We
believe that the dividend was accounted for and properly presented in the
financial statements in accordance with SFAS 128, paragraph 9 and EITF D-82,
which require that preferred dividends be shown separate from net income or
loss
regardless of the form of payment. As discussed above, we believe that the
preferential warrant dividends are similar to preferred dividends and,
therefore, would be presented similarly.
The
preferential warrant dividend of $48,666 in 2002 was provided to Louis Schnur,
a
major shareholder of the Company. As reported in the Company’s proxy statement
filed on April 30, 2002, Louis Schnur beneficially owned 607,000 common shares
of the Company at April 15, 2002, or 2.5% of the outstanding common stock.
In
addition, he owned 2,582,500 warrants to purchase common shares.
Of
the
$592,486 preferential warrant dividend in 2003, $176,472 was provided to Louis
Schnur and $416,014 was provided to Cranshire Capital, L.P., the two largest
unaffiliated, individual shareholders of the Company. As reported in the
Company’s proxy statement filed on May 7, 2003, Louis Schnur beneficially owned
2,275,421 common shares of the Company at April 30, 2003, or 6.5% of the
outstanding common stock. In addition, he owned 5,382,223 warrants to purchase
common shares. Also as reported in the Company’s proxy statement filed on May 7,
2003, Cranshire Capital L.P. beneficially owned 502,000 common shares of the
Company at April 30, 2003, or 1.4% of the outstanding common stock. In addition,
it owned 1,155,211 warrants to purchase common shares.
Note
11 - Commitments and Contingencies, page F19
4.
Please
file the November 2004 agreement with the University of Nevada, Las
Vegas
Research Foundation as an
exhibit.
The
November 2004 agreement with the University of Nevada, Las Vegas is attached
hereto as Exhibit 1 and will be filed as an exhibit to the next filing by the
Company.
Note
13 - Business Segment Information, page F-20
5.
Please
disclose the significant types of costs included in the corporate
and
other expense reconciling line item.
The
significant types of costs included in the corporate and other expense
reconciling line item are investor relations, business consulting, general
legal
expense, accounting and audit, general insurance expense, non-employee and
employee variable accounting stock option compensation expense and shareholder
information expense. This will be included in future disclosures.
Messrs.
Rufus Decker and Scott Watkinson
July
19,
2005 Page 5
6.
Please
revise your segment disclosures to include your revenues from external
customers for each product and service or each group of similar
products
and services as required by paragraph 37 of SFAS 131, as well as
the
geographic disclosures required by paragraph 38.
During
2004 Altair’s revenues were derived almost
entirely (99.3%) from contract service activities. The Company expects contract
services to continue to be the dominant revenue source during 2005 and,
accordingly has grouped similar contracts for presentation on the income
statement: license fees, contracts and grants, and commercial collaborations.
Product sales are not expected to be significant, disclosure of product revenue
based on product groupings will be made when product sales become
significant.
The
following table shows the geographic segment disclosure for the three years
ended December 31, 2004. Because Note 11 to the consolidated financial
statements discloses the $314,359 sales in Canada, it was not duplicated in
Note
13 to the consolidated financial statements. The Company will summarize this
disclosure in one table in future filings, as follows:
Revenues
from external customers were derived from the following geographic
areas:
Revenues
-
Revenues
-
Revenues
-
Year
Ended
Year
Ended
Year
Ended
Geographic
information (a):
December
31, 200